Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy

Tamura, K; Matsushita, Y; Watanabe, H; Motoyama, D; Ito, T; Sugiyama, T; Otsuka, A; Miyake, H

Tamura, K (corresponding author), Hamamatsu Univ Sch Med, Dept Urol, Shizuoka, Japan.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020; 38 (1):

Abstract

Purpose: To develop a novel model to predict outcomes in patients with previously treated metastatic renal cell carcinoma. Patients and methods: This ......

Full Text Link